These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6330151)

  • 1. Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women.
    Gelato MC; Pescovitz OH; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1984 Aug; 59(2):197-201. PubMed ID: 6330151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.
    Vance ML; Borges JL; Kaiser DL; Evans WS; Furlanetto R; Thominet JL; Frohman LA; Rogol AD; MacLeod RM; Bloom S
    J Clin Endocrinol Metab; 1984 May; 58(5):838-44. PubMed ID: 6423660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
    Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects.
    Sheldon WR; DeBold CR; Evans WS; DeCherney GS; Jackson RV; Island DP; Thorner MO; Orth DN
    J Clin Endocrinol Metab; 1985 Apr; 60(4):623-30. PubMed ID: 2982903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a growth hormone releasing factor in man.
    Gelato MC; Pescovitz O; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1983 Sep; 57(3):674-6. PubMed ID: 6409918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pancreatic growth hormone releasing factor (hpGRF): GRF- and GH-levels after bolus injection and infusion of hpGRF.
    von Werder K; Losa M; Stalla GK; Bock L; Müller OA
    Acta Neurochir (Wien); 1985; 75(1-4):81-7. PubMed ID: 2986424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].
    Shimizu T; Inoue K
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):82-96. PubMed ID: 3084310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone.
    Bowers CY; Reynolds GA; Durham D; Barrera CM; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1990 Apr; 70(4):975-82. PubMed ID: 2108187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic human pancreas growth hormone-releasing factor (hpGRF1-44-NH2) stimulates growth hormone secretion in normal men.
    Rosenthal SM; Schriock EA; Kaplan SL; Guillemin R; Grumbach MM
    J Clin Endocrinol Metab; 1983 Sep; 57(3):677-9. PubMed ID: 6409919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.
    Zanoboni A; Gibillini M; Cucchi MR; Zanoboni Muciaccia W; Zanussi C
    J Endocrinol Invest; 1988 Jun; 11(6):413-7. PubMed ID: 3145297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary stimulation by combined administration of four hypothalamic releasing hormones in normal men and patients.
    Cohen R; Bouquier D; Biot-Laporte S; Vermeulen E; Claustrat B; Cherpin MH; Cabrera P; Guidetti P; Ferry S; Bizollon CA
    J Clin Endocrinol Metab; 1986 May; 62(5):892-8. PubMed ID: 3007559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-endorphin suppresses adrenocorticotropin and cortisol levels in normal human subjects.
    Taylor T; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1983 Sep; 57(3):592-6. PubMed ID: 6308033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men.
    Lal S; Tolis G; Martin SB; Brown GM; Guyda H
    J Clin Endocrinol Metab; 1975 Nov; 41(5):827-32. PubMed ID: 1184719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-effect study of intranasal administration of growth hormone-releasing hormone-44-NH2 in healthy subjects.
    Khalfallah Y; Navailles B; Cohen R; Laville P; Kalita C; Cabrera P; Frangin G; Sassolas G
    J Clin Endocrinol Metab; 1990 Aug; 71(2):512-5. PubMed ID: 2116440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
    Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
    J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6.
    Gertz BJ; Barrett JS; Eisenhandler R; Krupa DA; Wittreich JM; Seibold JR; Schneider SH
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1393-7. PubMed ID: 8077339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose effect of human growth hormone-releasing factor and thyrotropin-releasing factor on hormone concentrations in lactating dairy cows.
    Lapierre H; Petitclerc D; Pelletier G; Delorme L; Dubreuil P; Morisset J; Gaudreau P; Couture Y; Brazeau P
    Domest Anim Endocrinol; 1990 Oct; 7(4):485-95. PubMed ID: 2124532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.